Intra-cellular Therapies, Inc.
ITCI
Revenue
175.38M
▲13.99M▲8.67%
3 Months ChangeAssets
1.32B
▲3.94M▲0.2984%
3 Months ChangeLiabilities
179.62M
▲3.73M▲2.12%
3 Months ChangeFree Cash Flow
-60.07M
▲23.35M▲27.99%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001628280-24-044196
2024-10-30
Form 8-K
ID: 0001193125-24-247021
2024-08-07
Form 10-Q
ID: 0001628280-24-035386
2024-08-07
Form 8-K
ID: 0001193125-24-195429
2024-06-18
Form 8-K
ID: 0001193125-24-163411
2024-06-18
Form 8-K
ID: 0001193125-24-163038
2024-05-07
Form 10-Q
ID: 0001628280-24-020849
2024-05-07
Form 8-K
ID: 0001193125-24-132586
2024-04-24
Form 8-K
ID: 0001193125-24-110139
2024-04-18
Form 8-K
ID: 0001193125-24-100960